Repurposing simeprevir, calpain inhibitor IV and a cathepsin F inhibitor against SARS-CoV-2 and insights into their interactions with Mpro
Author:
Affiliation:
1. Department of Biotechnology and Microbiology, Kannur University, Kannur, India
2. Department of Life Sciences, Kristu Jayanti College (Autonomous), Bengaluru, India
Funder
Council of Scientific and Industrial Research, India
Indian Council of Medical Research
Publisher
Informa UK Limited
Subject
Molecular Biology,General Medicine,Structural Biology
Link
https://www.tandfonline.com/doi/pdf/10.1080/07391102.2020.1813200
Reference41 articles.
1. Coronavirus Main Proteinase (3CL pro ) Structure: Basis for Design of Anti-SARS Drugs
2. The proximal origin of SARS-CoV-2
3. Drug repurposing against SARS-CoV-2 using E-pharmacophore based virtual screening, molecular docking and molecular dynamics with main protease as the target
4. Drug repositioning: identifying and developing new uses for existing drugs
5. Covid-19 — The Search for Effective Therapy
Cited by 27 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. SARS-CoV-2 Mpro inhibitor identification using a cellular gain-of-signal assay for high-throughput screening;SLAS Discovery;2024-09
2. An automated positive selection screen in yeast provides support for boron-containing compounds as inhibitors of SARS-CoV-2 main protease;Microbiology Spectrum;2024-08-20
3. Computational screening combined with well-tempered metadynamics simulations identifies potential TMPRSS2 inhibitors;Scientific Reports;2024-07-13
4. Trawling the Genome: Drug Target Identification in the Postgenomic Era;Drugs from Nature: Targets, Assay Systems and Leads;2024
5. Lipoxygenase inhibitory synthetic derivatives of methyl gallate regulate gene expressions of COX-2 and cytokines to reduce animal model arthritis;Scientific Reports;2023-06-30
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3